SynergyFinder: a web application for analyzing drug combination dose-response matrix data (Q36335514)

30 September 2017

SynergyFinder: a web application for analyzing drug combination dose-response matrix data. (English)

1 reference

30 September 2017

1 reference

Jing Tang

0 references

Tero Aittokallio

0 references

Aleksandr Ianevski

1 reference

30 September 2017

Liye He

series ordinal

1 reference

30 September 2017

language of work or name

English

0 references

publication date

4 April 2017

1 reference

30 September 2017

1 reference

inferred from page(s)

published in

Bioinformatics

1 reference

30 September 2017

1 reference

30 September 2017

1 reference

30 September 2017

2413-2415

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

30 September 2017

start time

4 April 2017

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Combenefit: an interactive platform for the analysis and visualization of drug combinations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

What is synergy? The Saariselkä agreement revisited

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

Combinatorial drug therapy for cancer in the post-genomic era.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

Targeting the cancer kinome through polypharmacology

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5554616

The problem of synergism and antagonism of combined drugs

1 October 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28379339

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/BIOINFORMATICS/BTX162

1 reference

journals/bioinformatics/IanevskiHAT17

30 September 2017

1 reference

DBLP Dataset 2021-01-02

release_zkvhp2banbfobfdyb2tgzshwxm

28 January 2021

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zkvhp2banbfobfdyb2tgzshwxm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

30 September 2017

PubMed publication ID

28379339

1 reference